Medtronic (NYSE:MDT) said today that it won breakthrough status from the FDA for its investigational personalized closed-loop insulin pump system.
The company touted its technology as enabling automated insulin delivery in a real-time, adaptable and personalized fashion.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic wins FDA’s breakthrough status for closed-loop insulin system appeared first on MassDevice.